Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Please note* We discount the cost of your first vial of medication by $100
Reading time: 5 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you
Nausea that persists beyond 46 hours post-injection or triggers vomiting suggests the dose is too high for your current tolerance
The safety profile of aleniglipron was consistent with the GLP-1 class, with no significant liver injury reported
Learn More Research review and sources Primary references and supporting sources Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Primary phase 2 obesity trial that informs current efficacy and tolerability context
US$ 24.57
US$ 21.34
US$ 26.07
US$ 23.61
US$ 29.01
US$ 20.23
US$ 21.33
